A clinical trial is a study conducted with actual patients, usually to evaluate a new treatment. Each study is designed to answer scientific questions and to find new and better ways to help patients.
SWOG S1823: A Study of miRNA371 in Patients with Germ Cell Tumors
Technical Title: A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
Disease Type: Newly diagnosed germ cell tumors (seminoma, non-seminoma, and other types of germ cell tumors)
Basic information: The purpose of this study is to see if increased levels of the blood marker miRNA 371 can be used to predict relapse in patients with germ cell cancers.
Research Procedures (not a complete list):
If you participate in this study, an extra tube of blood will be collected during your regular clinic visits for up to 3 years. The blood samples will be used to analyze miRNA 371.
Eligibility Criteria (not a complete list):
For More Detailed Information, contact:
For general information about UCLA Urology’s clinical trials, call the UCLA Urology Clinical Trials Office at (310) 206-5930.
More information regarding clinical trials can be found at:
Meet Our Doctors >
The Department of Urology at UCLA is one of the most progressive and comprehensive urology programs in the country. Our faculty members work side by side with research scientists for new cures and treatments for testicular cancer cancer.